Vaccine Miracles: Does JNJ Kill the Profit Path for MRNA and NVAX?
MRNA - Free Report) and Novavax (. NVAX - Free Report) -- right before the correction in growth stocks got rolling downhill fast!. The good news is that Moderna held up like a beast! I was recommending buying it between $130 and $140 and shares barely tumbled into that range this week as many other high-fliers saw -30% wallopings.www.zacks.com